Holen Sie sich die Stockscreener-App
13.75
0.39%
0.047
Finanzdaten der Syndax Pharmaceuticals Inc-Aktie (SNDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
89.39%
37.96
|
20.04 | 12.50 | 3.50 | - |
Operating Expenses
|
3.38%
107.31
|
103.80 | 102.08 | 77.72 | 79.51 |
| Benefits Costs and Expenses |
100.00%
-
|
104.89 | - | - | 143.96 |
| Costs And Expenses |
2.31%
107.31
|
104.89 | 102.08 | 77.72 | 66.25 |
| Operating Income/Loss |
17.20%
-69.35
|
-83.76 | -89.58 | -74.22 | -79.51 |
| Nonoperating Income/Loss |
129.02%
-2.494
|
-1.089 | 5.451 | 6.153 | 7.114 |
| Income/Loss From Continuing Operations Before Tax |
144.74%
37.96
|
-84.85 | 12.50 | -68.06 | -72.40 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
15.32%
-71.85
|
-84.85 | -84.13 | -68.06 | -72.40 |
|
Net Income/Loss
|
15.32%
-71.85
|
-84.85 | -84.13 | -68.06 | -72.40 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.19%
86.34
|
86.17 | 85.43 | 85.27 | 85.21 |
| Diluted Average Shares |
0.19%
86.34
|
86.17 | 85.43 | 85.27 | 85.21 |
| Basic Earnings Per Share |
15.31%
-0.83
|
-0.98 | -0.98 | -0.80 | -0.85 |
| Diluted Earnings Per Share |
15.31%
-0.83
|
-0.98 | -0.98 | -0.80 | -0.85 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.68%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):